openPR Logo
Press release

Inactivated Vaccine Market Opportunity Analysis By Top Players GlaxoSmithKline Plc, Seqirus, Valneva SE, Pfizer Inc., Merck & Co., Inc., Emergent BioSolutions, Bharat Biotech, and Sanofi.

11-19-2018 03:38 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Inactivated Vaccine Market Biotechnology Industry

Inactivated Vaccine Market Biotechnology Industry

New inactivated vaccines after completion of clinical studies are expected to boost growth of the inactivated vaccines market over the forecast period. For instance, in 2017, Merck’s investigational inactivated varicella zoster virus vaccine (V212) showed a decrease in the incidence of herpes zoster case by an estimated 64% in immunocompromised subjects in the first phase 3 trial. Clinical studies also revealed that V212 lessens the incidence of herpes zoster pain by around 69.5%. Moreover, V212 demonstrated 83.7% reduction in the incidence of post herpetic neuralgia. Rising prevalence of various viral and bacterial diseases around the globe have increased the demand for inactivated vaccines, which in turn will fuel the market growth. For instance, according to the World Health Organization (WHO) report in 2018, annual epidemics due to influenza were estimated to result in around 3 to 5 million cases of severe illness and around 290,000 to 650,000 deaths. Moreover, WHO 2018 report also showed that around 21 million cases and 222,000 typhoid-related deaths occur annually worldwide.

Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1905

Inactivated Vaccine Market – Regional Insights

On the basis of region, the global inactivated vaccine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global inactivated vaccines market, owing to the presence of key market players in this region, especially in the U.S. Moreover, favorable government support towards the growth of healthcare sector is also likely to accelerate the growth of inactivated vaccine market revenue in this region. For instance, in 2016, the U.S. Department of Health and Human Services shifted fund of around US$ 81 million from other projects, to continue the work on developing vaccines to fight Zika virus. Asia Pacific is expected to witness growth in the market, followed by Europe, owing to growing activities in the healthcare research and development of new innovative products. For instance, in 2013, Bharat Biotech launched JENVAC vaccine to provide long-term protection and immunogenicity against Japanese encephalitis. The important benefit of this novel fully indigenous inactivated vaccine is that it can be administered during disease epidemics, as it is an inactivated vaccine and is highly purified.

Inactivated Vaccine Market – Competitive Landscape

Major players operating in the global inactivated vaccine market include GlaxoSmithKline Plc, Seqirus, Valneva SE, Pfizer Inc., Merck & Co., Inc., Emergent BioSolutions, Bharat Biotech, and Sanofi. Major market players are involved in adopting market strategies such as mergers, acquisitions, partnership, collaborations, and development of new products with leading companies and research institutes, in order to retain dominant position in the market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved GlaxoSmithKline Plc’s Shingrix, a zoster vaccine recombinant for the prevention of shingles in adults above the age of 50 years. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.

A biological preparation that is used to provide active acquired immunity to a particular disease are called as vaccines. Vaccines are commonly of four types: live-attenuated vaccines, toxoid vaccines, subunit vaccines, and inactivated vaccines. Inactivated vaccines are created by inactivating a virus, bacteria or pathogens with the treatment of chemical (formaldehyde) or heat. These pathogens are grown in controlled culture condition and are killed to reduce their infectivity. Inactivated vaccines are not as effective as live-attenuated vaccines. Multiple booster shots and immunologic adjuvants are required to provide an effective immune response against the diseases. Inactivated vaccines are on the U.S. Recommended Childhood Immunization Schedule, which includes the seasonal influenza vaccine and inactivated polio vaccine. Less immunogenicity of older vaccines are propelling demand for newly developed innovative vaccines with better efficacy. Researchers and market players are investing in R&D for the development of safe and effective vaccines, thereby boosting growth of the inactivated vaccines market.

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/1905

Inactivated Vaccine Market – Taxonomy

On the basis of vaccine type, the global inactivated vaccine market is segmented into:

Viral Vaccine
Bacterial Vaccine
On the basis of method of inactivation, the global inactivated vaccine market is segmented into:

Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
On the basis of route of administration, the global inactivated vaccine market is segmented into:

Oral
Subcutaneous
Intravenous
Others
On the basis of geography, the global inactivated vaccine market is segmented into:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1905

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inactivated Vaccine Market Opportunity Analysis By Top Players GlaxoSmithKline Plc, Seqirus, Valneva SE, Pfizer Inc., Merck & Co., Inc., Emergent BioSolutions, Bharat Biotech, and Sanofi. here

News-ID: 1382625 • Views:

More Releases from Coherent Market Insights

Magnesium Oxide Market Size 2024: New Opportunities, Geographical Analysis, and Forecast Until 2031 | Martin Marietta Materials Inc., Grecian Magnesite S.A., Premier Magnesia
Magnesium Oxide Market Size 2024: New Opportunities, Geographical Analysis, and …
The latest report published by Coherent Market Insights highlights the growth prospects of the Magnesium Oxide Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such
Colostrum Market Key Growth Drivers, Latest Opportunities, Increasing Demand, and Forecast By 2024-2031 | APS Biogroup, Biostrum Nutritech Pvt. Ltd.
Colostrum Market Key Growth Drivers, Latest Opportunities, Increasing Demand, an …
The latest report published by Coherent Market Insights highlights the growth prospects of the Colostrum Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such as
Steam Turbine Market Size 2024: Industrial Insights including Manufacturing Details and Forecast Till 2031 | General Electric (GE), Siemens Energy
Steam Turbine Market Size 2024: Industrial Insights including Manufacturing Deta …
The latest report published by Coherent Market Insights highlights the growth prospects of the Steam Turbine Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such
Protein Supplements Market Share: Size, Growth, Key Vendors, Trends, and Forecast From 2024-2031 | Mondelez Company, Meiji Holdings Co Ltd.
Protein Supplements Market Share: Size, Growth, Key Vendors, Trends, and Forecas …
The latest report published by Coherent Market Insights highlights the growth prospects of the Protein Supplements Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such

All 5 Releases


More Releases for Inactivated

Global Inactivated Vaccine Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Inactivated Vaccine Market is projected to grow at a CAGR value of 10.5% from 2022 to 2027. Growing health consciousness and government efforts to support vaccination, technological developments and infrastructure upgrades in the healthcare system, increased emphasis on research studies, and cooperation among various top research facilities in the domain to find a new methodology to
Global Hepatitis A Vaccine, Inactivated Market Research Report
This report studies the global Hepatitis A Vaccine, Inactivated market status and forecast, categorizes the global Hepatitis A Vaccine, Inactivated market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline Merck Sanofi Berna Biotech Norvatis Sinovac Geographically, this report studies the top
Inactivated Vaccine Market - Size, Share, Outlook, and Forecast till 2026
A vaccine that consists of virus particles, bacteria or other pathogens, which were grown in culture and then killed using heat or formaldehyde is called as inactivated vaccine or killed vaccine. The infectivity is reduced, as pathogens for inactivated vaccines are grown under controlled conditions and are killed. Inactivated vaccines are classified into whole virus vaccines, split virus vaccines, and subunit vaccines based on the method of inactivation of virus. Get
Inactivated Vaccine Market: Drivers, Regional Analysis, and Competitive Landscap …
A biological preparation that is used to provide active acquired immunity to a particular disease are called as vaccines. Vaccines are commonly of four types: live-attenuated vaccines, toxoid vaccines, subunit vaccines, and inactivated vaccines. Inactivated vaccines are created by inactivating a virus, bacteria or pathogens with the treatment of chemical (formaldehyde) or heat. These pathogens are grown in controlled culture condition and are killed to reduce their infectivity. Inactivated vaccines
Inactivated Vaccines Market Size will Observe Substantial Growth by 2025
A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body’s immune system is stimulated by the agent, which is recognized as a foreign body by this immune
Inactivated Vaccines Market Foraying into Emerging Economies During 2017 - 2025
A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body’s immune system is stimulated by the agent, which is recognized as a foreign body by this immune